Israel - English - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 1 mg - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

Israel - English - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 2 mg - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

Israel - English - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 3 mg - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

Israel - English - Ministry of Health

unipharm ltd, israel - risperidone - coated tablets - risperidone 4 mg - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

Israel - English - Ministry of Health

unipharm ltd, israel - risperidone - solution - risperidone 1 mg/ml - risperidone - rispond is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of rispond was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. rispond is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. rispond is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. rispond is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distractibility or poor judgment including disruptibe or aggressive behaviors.

Israel - English - Ministry of Health

rafa laboratories ltd - hydromorphone hydrochloride - capsules - hydromorphone hydrochloride 2.6 mg - hydromorphone - hydromorphone - treatment of severe cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - hydromorphone hydrochloride - capsules - hydromorphone hydrochloride 1.3 mg - hydromorphone - hydromorphone - treatment of severe cancer pain.

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Israel - English - Ministry of Health

dexcel ltd, israel - doxycycline as hyclate - tablets - doxycycline as hyclate 100 mg - doxycycline - doxycycline has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of gram-positive and gram-negative bacteria and certain other microorganisms.-respiratory tract infections: pneumonia and other lower respiratory tract infections due to susceptible strains of streptococcus pneumoniae, haemophilus influenzae, klebsiella pneumoniae, moraxella catarrhalis and other organisms. mycoplasma pneumonia. treatment of chronic bronchitis, sinusitis.-urinary tract infections: infections caused by susceptible strains of klebsiella species, enterobacter species, escherichia coli, streptococcus faecalis and other organisms.-sexually transmitted diseases: infections due to chlamdyia trachomatis including uncomplicated urethral, endocervical or rectal infections. non-gonococcal urethritis caused by ureaplasma urealiticum (t-mycoplasma). doxylin 100 is also indicated in infections due to calymmatobacterium granulomatis. doxylin is an alternative drug in the treatment of gonorrhoea and syphilis.since doxycycline is a member of the tetracycline series of antibiotics, it may be expected to be useful in the treatment of infections which respond to other tetracyclines, such as:-ophthalmic infections: treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.-rickettsial infections: rocky mountain spotted fever, typhus group, q fever, coxiella endocarditis. -other infections: psittocosis, brucellosis (in combination with streptomycin), cholera, bubonic plague, louse and tick-borne relapsing fever including stage 1 and stage 2 lyme disease, leptospirosis, tularaemia glanders, chloroquine-resistant falciparum malaria and acute intestinal amoebiasis (as an adjunct to amoebicides). infections due to susceptible strains of bacteroides species, and listeria species. -doxylin is an alternative drug in the treatment of leptospirosis, gas gangrene and tetanus. -doxylin is indicated for prophylaxis in the following conditions: scrub typhus, traveller's diarrhoea (enterotoxigenic escherichia coli), leptospirosis, malaria and cholera. -anthrax due to bacillus anthracis, including inhalational anthrax (post exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis.